SWM
ABBV icon

Stonebridge Wealth Management’s AbbVie ABBV Stock Holding History

Stonebridge Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Sell
13,217
-13
-0.1% -$2.8K 2.98% 10
2026
Q1 		$2.88M Buy
13,230
+13
+0.1% +$2.88K 2.76% 10
2025
Q4 		$3.02M Sell
13,217
-49
-0.4% -$11.2K 2.85% 11
2025
Q3 		$3.07M Hold
13,266
– – 2.64% 14
2025
Q2 		$2.46M Buy
+13,266
New +$2.47M 2.32% 12

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Stonebridge Wealth Management's ABBV Position: Q2 2026 in Review

Stonebridge Wealth Management reduced its AbbVie (ABBV) stake by 0.1% in Q2 2026, selling an estimated $2.8K and leaving 13,217 shares worth $3.33M. The position accounts for 2.98% of the portfolio, ranked #10.

Stonebridge Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 902 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stonebridge Wealth Management held 13,217 shares of AbbVie worth $3.33M as of Q2 2026.
  • Stonebridge Wealth Management sold 13 AbbVie shares in Q2 2026, an estimated $2.8K.
  • AbbVie made up 2.98% of Stonebridge Wealth Management's portfolio in Q2 2026, its #10 holding.
  • Stonebridge Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 902 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stonebridge Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.